Opiate Dependence
Conditions
Keywords
opiate dependence, compliance monitoring, substitution treatment
Brief summary
The aim of the study is to examine whether electronic compliance monitoring in real time could offer some advantages compared to normal electronic monitoring in opioid substitution treatment. The investigators would also like know whether this method could enable the quick detection of possible problems in medication intakes and/or prevent the abuse or diversion of substitution medications.
Interventions
Electronic compliance monitoring with monitoring device (Pharma DDSi, Stora Enso) is used in control group (n=6) and device with mobile phone in intervention group (n=6). Patients in intervention group send every day the information of their medication intakes with the mobile phone to the clinic. This intervention is tested in pilot study (n=2-3) before the actual study begins.
Sponsors
Kuopio University Hospital
Study design
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Opiate dependence * Suboxone treatment * Stable substitution medication dose
Exclusion criteria
* Chaotic situation in life
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| The effectiveness of treatment (Treatment Outcomes Profile TOP) | Every four weeks. | Structured interview designed to measure the effectiveness and outcomes of opioid substitution treatment. Interview covers the last four weeks so it can be done every four weeks. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Patients´opinions about the treatment. | Once when the study phase ends (after the 8 th study week). | Questionnaire designed for this study to explore patients' opinions on the compliance monitoring and it's effect on the treatment and abuse and/or diversion of medications. |
Outcome results
None listed